genomics-based medicine coming into view
DESCRIPTION
NextCODE’s interpretation technology will be an increasingly important asset in delivering insights from the wealth of genomic data being produced.TRANSCRIPT
![Page 1: Genomics-Based Medicine Coming into View](https://reader035.vdocuments.us/reader035/viewer/2022062705/556539d1d8b42ad7648b499c/html5/thumbnails/1.jpg)
Genomics-Based Medicine Coming into View
Hannes Smarason
Genome Sequencing |Personalized Medicine | Transforming Health Care
![Page 2: Genomics-Based Medicine Coming into View](https://reader035.vdocuments.us/reader035/viewer/2022062705/556539d1d8b42ad7648b499c/html5/thumbnails/2.jpg)
The practice and adoption of genomic medicine is accelerating as technologies improve, costs fall and new insights drive better patient care. While many companies are supporting this emerging field, a select few are providing the unique perspectives and capabilities to advance progress even faster.
![Page 3: Genomics-Based Medicine Coming into View](https://reader035.vdocuments.us/reader035/viewer/2022062705/556539d1d8b42ad7648b499c/html5/thumbnails/3.jpg)
Progress in Action
• NextCODE Health made headlines less than a year ago with its launch and funding announcement.
• The company quickly gained recognition for its unique capabilities to address unmet needs in the genomics space through a massive genomics database that interprets DNA samples to identify relevant disease markers. (See the features in Xconomy, Bio-IT World and PLOS Blog.)
• The company was later mentioned in Nature Biotechnology News for its potential contributions to genome studies by leveraging reference data from deCODE’s Icelandic database.
![Page 4: Genomics-Based Medicine Coming into View](https://reader035.vdocuments.us/reader035/viewer/2022062705/556539d1d8b42ad7648b499c/html5/thumbnails/4.jpg)
Accelerating Progress• Its rapid trajectory since launch and the utility of its genomic analysis
technology was featured in BioCentury in May, with testimonials from clinicians using NextCODE capabilities.
• In June, it was featured in a major interview with Bio-IT World, and the company continues to expand.
• Since then, NextCODE has announced several programs through which world leaders in genomics research are applying its interpretation and analysis technology:– A collaboration with the ANZAC Research Institute in Sydney Australia to use
NextCODE’s technology to research a rare disease, X-linked Charcot-Marie-Tooth syndrome
– And a new program with University College Dublin’s ACoRD to study autism and rare diseases
![Page 5: Genomics-Based Medicine Coming into View](https://reader035.vdocuments.us/reader035/viewer/2022062705/556539d1d8b42ad7648b499c/html5/thumbnails/5.jpg)
As more organizations employ genomics in major research initiatives, NextCODE’s interpretation technology will be an increasingly important asset in delivering meaningful insights from the wealth of genomic data being produced.